Survival of dogs with pituitary‐dependent hyperadrenocorticism treated twice daily with low doses of trilostane



Downloads per month over past year

García San José, Paula and Arenas Bermejo, Carolina and Alonso Miguel, Daniel and González Sanz, Sandra and Clares Moral, Irene and Portero Fuentes, Miriam and Pérez Alenza, María Dolores (2022) Survival of dogs with pituitary‐dependent hyperadrenocorticism treated twice daily with low doses of trilostane. Veterinary Record . ISSN 0042-4900

[thumbnail of Veterinary Record - 2022 - Garc a San Jos - Survival of dogs with pituitary‐dependent hyperadrenocorticism treated twice.pdf]
Creative Commons Attribution Non-commercial No Derivatives.


Official URL:


Twice daily low trilostane doses have proven to be effective to manage canine Cushing's syndrome. However, survival and prognostic factors in dogs treated with this protocol have not been evaluated. The aim of the study was to evaluate survival and prognostic factors, including systolic blood pressure (SBP) at diagnosis, in dogs with pituitary-dependent hypercortisolism (PDH) treated with low trilostane doses.

Medical records of 91 dogs newly diagnosed with PDH initially treated with 0.2–1.1 mg/kg of trilostane twice daily were retrospectively included. Survival times were calculated using the Kaplan–Meier estimator. Univariable and multivariable analysis were performed using the Cox proportional hazard regression analysis.

Overall, median survival was 998 days (range 26–1832 days, 95% confidence interval = 755–1241 days). In the multivariable analysis, age (hazard ratio [HR] = 1.337, p < 0.001), presence of calcinosis cutis (HR = 5.271, p < 0.001), body condition score (BCS) ≤3/9 (HR = 8.100, p < 0.001) and higher platelet count (HR = 1.002, p = 0.022) were negatively correlated with survival. SBP was not associated with survival.

Low-dose trilostane treatment twice daily provides slightly longer survival than previously reported for dogs with PDH treated once or twice daily at higher doses. Older age, presence of calcinosis cutis, low BCS and higher platelet count, but not systemic hypertension, are predictive of poorer prognosis in dogs with PDH.

Item Type:Article
Additional Information:

CRUE-CSIC (Acuerdos Transformativos 2022)

Subjects:Medical sciences > Veterinary > Veterinary pathology
Medical sciences > Veterinary > Veterinary pharmacology
ID Code:72366
Deposited On:19 May 2022 15:27
Last Modified:20 May 2022 07:09

Origin of downloads

Repository Staff Only: item control page